Private Capital Group’s NeoGenomics NEO Stock Holding History

Private Capital Group’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-108	Closed	-$1K	–	2032
2022 Q1	$1K	Buy	+108	New	+$2.27K	﹤0.01%	1967
2019 Q4	–	Sell	-11	Closed	–	–	2126
2019 Q3	$0	Buy	+11	New	+$258	﹤0.01%	2393

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Private Capital Group's NEO Position: Q2 2022 in Review

Private Capital Group sold out of NeoGenomics (NEO) in Q2 2022, closing a stake of 108 shares — an estimated $1K sold.

Private Capital Group first reported a position in NEO in Q3 2019 and held it in 2 quarters. The position peaked at $1K in Q1 2022. 239 funds tracked by Wall St. Rank hold NEO as of Q2 2022.

Private Capital Group reported no remaining NeoGenomics position as of Q2 2022 after selling out during the quarter.
Private Capital Group sold 108 NeoGenomics shares in Q2 2022, an estimated $1K.
Private Capital Group first reported a position in NeoGenomics in Q3 2019 and held it in 2 quarters.
Private Capital Group's NeoGenomics position peaked at $1K in Q1 2022.
239 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.